Get the Stockscreener App
11.03
0.36%
0.04
After Hours:
11.02
-0.010
-0.09%
Overview
News
Price History
Option Chain
Financials
Why WBA Down?
Discussions
Forecast
Stock Split
Dividend History
Walgreens Boots Alliance Inc stock is traded at $11.03, with a volume of 7.74M.
It is up +0.36% in the last 24 hours and down -1.08% over the past month.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
See More
Previous Close:
$10.99
Open:
$10.97
24h Volume:
7.74M
Relative Volume:
0.37
Market Cap:
$9.42B
Revenue:
$147.66B
Net Income/Loss:
$-8.64B
P/E Ratio:
-1.1019
EPS:
-10.01
Net Cash Flow:
$-363.00M
1W Performance:
+1.29%
1M Performance:
-1.08%
6M Performance:
+18.09%
1Y Performance:
-38.07%
1-Day Range:
$10.95
$11.05
1-Week Range:
$10.80
$11.08
52-Week Range:
$8.08
$18.83
Walgreens Boots Alliance Inc Stock (WBA) Company Profile
Name
Walgreens Boots Alliance Inc
Sector
Industry
Phone
(847) 315-2500
Address
108 WILMOT ROAD, DEERFIELD, IL
Compare WBA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WBA
Walgreens Boots Alliance Inc
|
11.03 | 9.42B | 147.66B | -8.64B | -363.00M | -10.01 |
|
HITI
High Tide Inc
|
2.38 | 186.97M | 376.07M | -22.41M | 18.73M | -0.298 |
|
WGRX
Wellgistics Health Inc
|
4.27 | 170.90M | 0 | 0 | 0 | 0.00 |
|
PETS
Petmed Express Inc
|
3.52 | 63.83M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
HKPD
Hong Kong Pharma Digital Technology Holdings Ltd
|
0.97 | 9.97M | 0 | 0 | 0 | 0.00 |
Walgreens Boots Alliance Inc Stock (WBA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-20-24 | Downgrade | HSBC Securities | Hold → Reduce |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Dec-22-23 | Initiated | HSBC Securities | Hold |
| Oct-23-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-03-23 | Reiterated | Morgan Stanley | Underweight |
| Jun-28-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Initiated | Loop Capital | Buy |
| Nov-23-22 | Resumed | Morgan Stanley | Underweight |
| Nov-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Nov-18-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-11-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Mar-25-21 | Reiterated | Deutsche Bank | Hold |
| Jan-11-21 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-11-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Resumed | Credit Suisse | Neutral |
| Apr-06-20 | Upgrade | UBS | Sell → Neutral |
| Apr-03-20 | Upgrade | Deutsche Bank | Sell → Hold |
| Dec-11-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-30-19 | Reiterated | Pivotal Research Group | Hold |
| Oct-23-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-27-19 | Resumed | RBC Capital Mkts | Sector Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Sell |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Apr-03-19 | Downgrade | Loop Capital | Buy → Hold |
| Apr-03-19 | Reiterated | Pivotal Research Group | Hold |
| Mar-08-19 | Reiterated | BofA/Merrill | Underperform |
| Jan-17-19 | Initiated | UBS | Sell |
| Dec-19-18 | Resumed | Wolfe Research | Peer Perform |
| Dec-14-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-15-18 | Reiterated | Pivotal Research Group | Hold |
| Oct-08-18 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-10-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-09-18 | Downgrade | Citigroup | Buy → Neutral |
| Jul-02-18 | Reiterated | Pivotal Research Group | Hold |
| Jun-29-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Walgreens Boots Alliance Inc Stock (WBA) Latest News
(WBA) Technical Data - news.stocktradersdaily.com
Walgreens to help cover tuition for techs going to pharmacy school - Crain's Chicago Business
Walgreens is on the Hook For up to $350 Million After Filling Illegal Prescriptions - Cars 108
Walgreens leader in Texas sees increased demand for measles vaccine - Walgreens Boots Alliance
Walgreens reaches $300m deal over opioid prescriptions claims - Yahoo Finance
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline | WBA Stock News - GuruFocus
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline - Business Wire
Jim Cramer on Walgreens (WBA): “Clock’s Ticking on That One” - Insider Monkey
Understanding the Risks of Investing in Walgreens Boots Alliance Inc (WBA) - knoxdaily.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, WBA, RDW on Behalf of Shareholders - PR Newswire
In time for Earth Day, a new pilot aims to further reduce waste in our supply chain - Walgreens Boots Alliance
Walgreens To Pay Up To $350 Mln For Opioid Settlement - RTTNews
Walgreens to settle invalid prescriptions case for $300 million - The Arkansas Democrat-Gazette
Walgreens (WBA) Settles Opioid Prescription Allegations for $350M - GuruFocus
Walgreens to pay $350M in U.S. opioid settlement (WBA:NASDAQ) - Seeking Alpha
Walgreens (WBA) Agrees to $3.5 Billion Settlement Over Opioid Prescriptions - GuruFocus
Walgreens agrees to pay up to $350 million to U.S. government in opioid settlement - MarketWatch
Walgreens to pay $300 million to settle claims it illegally filled invalid opioid prescriptions - KPAX News
Deerfield-based Walgreens to pay $300 million to settle federal allegations of unlawfully filling opioid scripts - Lake and McHenry County Scanner
Long-Term Investors in shares of Walgreens Boots Alliance, Inc. - openPR.com
WBA Stock Quote Price and Forecast - CNN
Sector Update: Health Care - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Walgreens settlement: Pharmacy chain agrees to pay up to $350M for illegally filling unlawful opioid prescriptions - ABC7 Chicago
Walgreens Must Pay Hefty Fine In Opioid CaseWalgreens Boots Alliance (NASDAQ:WBA) - Benzinga
Walgreens to pay $300 million in US opioid settlement - Reuters
Walgreens paying up to $350M as it tries to close the book on opioid lawsuits - Crain's Chicago Business
Walgreens Boots Alliance (WBA) Settles Opioid Prescription Allegations for $300 Million - GuruFocus
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says By Reuters - Investing.com
Walgreens to Pay Up to $350 Million to Settle Claims It Played a Role in the US Opioid Crisis - marketscreener.com
6.5M Pounds of Medications Safely Disposed: Walgreens Leads National Drug Take Back Day 2025 - Stock Titan
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says - NewsBreak: Local News & Alerts
Boots Workers Worry About Sycamore Cost Cuts - The Business of Fashion
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day this Saturday - Walgreens Boots Alliance
Townsquare Capital LLC Cuts Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Short Interest in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Decreases By 20.2% - Defense World
Walgreens To Pay DOJ $300M Over Invalid Prescriptions - Law360
Walgreens Boots Alliance (WBA) Reaches Settlement with DOJ Over Opioid Dispensing Rules - GuruFocus
Walgreens settles opioid litigation for $300 million - Investing.com
Hanes' CLO Resigns For 'Another Business Opportunity' - Law360
Investors | Global Leaders in Retail Pharmacy | WBA - Walgreens Boots Alliance
Walgreens Boots Alliance (WBA): Strong Industry, Solid Earnings Estimate Revisions - TradingView
6 ways your pharmacist can support your health and wellness - Walgreens Boots Alliance
Wells Fargo & Company MN Has $10.09 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Franklin Resources Inc. Decreases Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Arrowhead Pharma Taps Walgreens Finance Chief to Lead Commercial Stage Transition - Stock Titan
Walgreens: Acquisition Is The Best-Case Scenario For The Company - Seeking Alpha
Sycamore Partners’ plan to takeover Walgreens ‘incredibly risky,’ analyst says - Healthcare Brew
More Walgreens Locations Set to Shut Down in Connecticut This May - NewsBreak: Local News & Alerts
No shortage of egg-inspired options this Easter at Walgreens - Walgreens Boots Alliance
Form PREM14A Walgreens Boots Alliance For: Apr 14 - StreetInsider
Walgreens Boots Alliance Inc Stock (WBA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):